T-Cell Lymphoma Clinical Trials

A listing of T-Cell Lymphoma medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 185 clinical trials
Trial of Intravenous Fenretinide Emulsion for Patients With Relapsed/Refractory Peripheral T-cell Lymphomas

This study addresses the hypothesis that intermittent treatment with fenretinide intravenous emulsion will induce objective responses in patients with relapsed or refractory Peripheral T-cell

ct scan
measurable disease
systemic therapy
refractory peripheral t-cell lymphoma
t-cell lymphoma
  • 0 views
  • 29 Jul, 2019
  • 11 locations
Durvalumab in Different Combinations With Pralatrexate Romidepsin and Oral 5-Azacitidine for Lymphoma

romidepsin (Arm A); durvalumab, pralatrexate, and romidepsin (Arm B); durvalumab and romidepsin (Arm C); or durvalumab and oral 5-azacitidine (Arm D), in patients with peripheral T-cell lymphoma (PTCL). The

peripheral t-cell lymphoma
gilbert's syndrome
platelet count
neutrophil count
romidepsin
  • 22 views
  • 03 Feb, 2020
  • 2 locations
GDP in Frontline Chemotherapy for Patients With PTCL-NOS

This study is to evaluate the efficacy and safety of GDP (gemcitabine, dexamethasone, and cisplatin) chemotherapy in patients with peripheral T-cell lymphoma-NOS as frontline treatment.

dexamethasone
platelet count
measurable disease
neutrophil count
t-cell lymphoma
  • 22 views
  • 08 Nov, 2020
  • 1 location
B-MAD Chemotherapy in Newly-diagnosed Extranodal NK/ T-cell Lymphoma

Study Title: Phase I/II study of brentuximab vedotin and methotrexate/ L-asparaginase/ dexamethasone (B-MAD) chemotherapy in patients with newly-diagnosed Extranodal NK/T-cell Lymphoma

  • 1 views
  • 28 Apr, 2019
  • 1 location
VT-EBV-N for Treatment of Severe in EBV Positive Extranodal NK/T Cell Lymphoma Patients

The study aims to evaluate the efficacy and safety of VT-EBV-N (EBV-CTL) administration in ENKL patients after complete remission (CR). This is to prove the effect of VT-EBV-N (EBV-CTL) in prevention of ENKL relapse compared to placebo, by checking the primary endpoint of DFS rate (disease free survival, no relapse …

  • 0 views
  • 10 Nov, 2019
  • 6 locations
Maintenance Treatment of Chidamide in Stage IV or Relapsed/Refractory Extranodal NK/T-cell Lymphoma

Extranodal natural killer/T-cell lymphoma, nasal type (NKTCL) is a highly aggressive peripheral T-cell lymphoma (PTCL). Patients with newly diagnosed stage IV and relapsed/refractory have poor

  • 3 views
  • 08 Nov, 2020
  • 1 location
Chidamide Combined With CHOPE Regimen for Peripheral T-cell Lymphoma Patients

Chidamide With Cyclophosphamide, Doxorubicin, Vincristine, Prednisone and Etoposide for Peripheral T Cell Lymphoma Patients : a Prospective, Randomized Controlled, Open Label, Phase II Clinical

  • 5 views
  • 08 Nov, 2020
  • 1 location
Chidamide With PET Regimen for Angioimmunoblastic T Cell Lymphoma (PET: Prednisone Etoposide and Thalidomide)

This study aims to investigate the efficacy and safety of PET regimen combined with Chidamide for angioimmunoblastic T cell lymphoma patients.

prednisone
thalidomide
lymphoma
platelet count
neutrophil count
  • 0 views
  • 08 Nov, 2020
  • 1 location
Avastin+ GemAOD As First-Line Treatment in NK/T Cell Lymphoma

patients with untreated natural killer(NK)/T cell lymphoma

  • 9 views
  • 07 Nov, 2020
  • 1 location
CHP-BV Followed by Consolidation With High-dose Therapy / ASCT as Frontline Treatment of Patients With EATL Type 1.

It has been recently reported that EATL type 1, but not refractory coeliac disease, strongly expressed CD30 and might benefit from brentuximab vedotin. Since the safety profile of the combination brentuximab vedotin and CHP is known and since the role of etoposide as part of induction regimen is not demonstrated, …

  • 0 views
  • 16 Jun, 2019
  • 1 location